GS-1219

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-1219, covering 2025-10-21 to 2025-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of GS-1219 in Participants With HIV-1 [Phase 1]